Max Healthcare Institute Limited
Max Healthcare Institute Limited Fundamental Analysis
Max Healthcare Institute Limited (MAXINDIA.BO) shows weak financial fundamentals with a PE ratio of 64.75, profit margin of 17.43%, and ROE of 15.09%. The company generates $3.6B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 60.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze MAXINDIA.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakMAXINDIA.BO struggles to generate sufficient returns from assets.
Valuation Score
WeakMAXINDIA.BO trades at a premium to fair value.
Growth Score
WeakMAXINDIA.BO faces weak or negative growth trends.
Financial Health Score
ModerateMAXINDIA.BO shows balanced financial health with some risks.
Profitability Score
ModerateMAXINDIA.BO maintains healthy but balanced margins.
Key Financial Metrics
Is MAXINDIA.BO Expensive or Cheap?
P/E Ratio
MAXINDIA.BO trades at 64.75 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, MAXINDIA.BO's PEG of 14.35 indicates potential overvaluation.
Price to Book
The market values Max Healthcare Institute Limited at 9.14 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 41.20 times EBITDA. This signals the market has high growth expectations.
How Well Does MAXINDIA.BO Make Money?
Net Profit Margin
For every $100 in sales, Max Healthcare Institute Limited keeps $17.43 as profit after all expenses.
Operating Margin
Core operations generate 30.58 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $15.09 in profit for every $100 of shareholder equity.
ROA
Max Healthcare Institute Limited generates $8.72 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Max Healthcare Institute Limited produces operating cash flow of $362.84M, showing steady but balanced cash generation.
Free Cash Flow
Max Healthcare Institute Limited generates weak or negative free cash flow of $-18.33M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.42 in free cash annually.
FCF Yield
MAXINDIA.BO converts -0.04% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
64.75
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
14.35
vs 25 benchmark
P/B Ratio
Price to book value ratio
9.14
vs 25 benchmark
P/S Ratio
Price to sales ratio
11.29
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.33
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.79
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.15
vs 25 benchmark
ROA
Return on assets percentage
0.09
vs 25 benchmark
ROCE
Return on capital employed
0.18
vs 25 benchmark
How MAXINDIA.BO Stacks Against Its Sector Peers
| Metric | MAXINDIA.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 64.75 | 28.54 | Worse (Expensive) |
| ROE | 15.09% | 738.00% | Weak |
| Net Margin | 17.43% | -43982.00% (disorted) | Strong |
| Debt/Equity | 0.33 | 0.34 | Neutral |
| Current Ratio | 0.79 | 2806.01 | Weak Liquidity |
| ROA | 8.72% | -14624.00% (disorted) | Weak |
MAXINDIA.BO outperforms its industry in 1 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Max Healthcare Institute Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation